Clinician-Reported Barriers to Implementing Breast Cancer Chemoprevention in the UK: A Qualitative Investigation

Publisher： Karger

E-ISSN： 1662-8063|19|4|239-249

ISSN： 1662-4246

Source： Public Health Genomics, Vol.19, Iss.4, 2016-07, pp. : 239-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer chemoprevention by the antioxidant tempol in Atm -deficient mice

By Schubert Ralf  

Human Molecular Genetics, Vol. 13, Iss. 16, 2004-08 ,pp. : 1793-1802

Oxford University Press

Access to resources Recommend Favorite

Ethnic, Racial and Cultural Identity and Perceived Benefits and Barriers Related to Genetic Testing for Breast Cancer among At-Risk Women of African Descent in New York City

By  

Public Health Genomics, Vol. 14, Iss. 6, 2011-05 ,pp. : 356-370

Karger

Access to resources Recommend Favorite

Clinical Proteomics of Breast Cancer

By  

Current Genomics, Vol. 11, Iss. 7, 2010-11 ,pp. : 528-536

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor

By Erker Laura  

Human Molecular Genetics, Vol. 14, Iss. 12, 2005-06 ,pp. : 1699-1708

Oxford University Press

Access to resources Recommend Favorite

Mitochondria and Familial Predisposition to Breast Cancer

By  

Current Genomics, Vol. 14, Iss. 3, 2013-05 ,pp. : 195-203

Bentham Science Publishers

Access to resources Recommend Favorite